Treatment of melanoma with antisense oligonucleotides to...

Details Treatment of melanoma with antisense oligonucleotides to... Treatment of melanoma with antisense oligonucleotides to...

A - Human Necessities

61

K

A61K 48/00 (2006.01) C07H 21/00 (2006.01) C12N 15/11 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2123611

2123611 9309789 PCTABS00022 Melanoma is treated by administering oligonucleotides having a nucleotide sequence complementary to at least a portion of the mRNA transcript of the human c-myb gene. These "antisense" oligonucleotides are hybridizable to the c-myb mRNA transcript.

Affiliated with

Also associated with

Rating

Treatment of melanoma with antisense oligonucleotides to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of melanoma with antisense oligonucleotides to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of melanoma with antisense oligonucleotides to... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1510173